A study of over half a million older adults shows that those who received the Shingrix shingles vaccine had a 24% lower chance of developing dementia over four years compared to those who were unvaccinated.
- Vaccinated adults had an 18.8% dementia diagnosis rate versus 24.6% for unvaccinated
- Study used data from 509,926 seniors admitted to over 5,500 nursing facilities
- Findings suggest Shingrix may provide neuroprotective benefits beyond shingles prevention
What happened
Researchers conducted a large-scale study examining the effects of the recombinant shingles vaccine, Shingrix, on dementia risk among adults aged 66 and older residing in skilled nursing facilities. Using health records and Medicare claims involving more than 500,000 participants, they compared dementia outcomes for those vaccinated against shingles to those who were not vaccinated. Over a follow-up period of four years, individuals who received at least one dose of Shingrix showed a 24% lower risk of being diagnosed with dementia.
This study, led by Brown University and published in Annals of Internal Medicine, represents the first such investigation focused solely on the newer Shingrix vaccine. It builds upon previous research that suggested older shingles vaccines might also lower dementia risk, and it applies a method to mimic randomized trial conditions using existing data. The authors reported their findings while noting careful adjustments for differences in demographics and health status between vaccinated and unvaccinated groups.
Why it feels good
Discovering that a widely available vaccine could provide cognitive benefits is encouraging news for older adults and their caregivers. Dementia continues to be a challenging and widespread health concern with few effective preventive options, so the potential added protection from a shingles vaccine offers hope for enhancing quality of life in later years. The study’s results reinforce the important connection between overall physical health and brain function, suggesting that interventions protecting against physical illness may also guard mental acuity.
While the research does not prove a direct cause-and-effect relationship, it supports growing evidence that vaccines might have broader, surprising benefits. The idea that keeping your body healthy with immunizations could also help preserve mental health is a comforting message, especially as the population ages and dementia rates rise worldwide.
What to enjoy or watch next
Further research, including clinical trials, will be essential to confirm whether the Shingrix vaccine directly reduces dementia risk and to understand the mechanisms behind this association. Meanwhile, older adults and healthcare providers might consider shingles vaccination as a valuable preventive step not only for protecting against shingles but also possibly for maintaining cognitive health over time.
Public health efforts to increase awareness and accessibility of the Shingrix vaccine remain important, especially among older populations entering nursing care settings. Keeping an eye on new studies related to vaccine impacts on brain health holds promise and represents an exciting area of medical science where simple health measures could lead to profound benefits.